For kidney transplant assessment
Surveilling your new kidney with a more precise blood draw
More informed, better protection
You and your provider understand the importance of preserving the function of a newly transplanted kidney. Achieving this goal could mean avoiding both dialysis and returning to the transplant list.
Early, informed treatment of underlying disease and patient adherence to medications are essential to preserving kidney function.
How does it work?
From a single blood draw, Prospera measures the amount of donor DNA from your transplanted kidney in your blood. This helps your care team assess all types of rejection more precisely than available standard assessment tools.1-4
1Altug Y et al. Analytical validation of a single-nucleotide polymorphism-based donor-derived cell-free DNA assay for detecting rejection in kidney transplant patients. Transplantation. 2019
2Sigdel TK et al. Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR. J Clin Med. 2019;8(1):19.
3Grskovic M et al. Validation of a clinical-grade assay to measure donor-derived cell-free DNA in solid organ transplant recipients. J Mol Diagn.2016;18(6):890-902.
4Bloom RD et al. Cell-free DNA and active rejection in kidney allografts. J Am Soc Nephrol. 2017;28(7):2221-2232. doi: 10.1681/ASN.2016091034.